Načítá se...
Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19
Objective: Although type 2 diabetes mellitus (T2DM) has been reported as a risk factor for coronavirus disease 2019 (COVID-19), the effect of pharmacologic agents used to treat T2DM, such as metformin, on COVID-19 outcomes remains unclear. Metformin increases the expression of angiotensin converting...
Uloženo v:
| Vydáno v: | Endocr Pract |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7834011/ https://ncbi.nlm.nih.gov/pubmed/33471718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/EP-2020-0466 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|